WV
Windamere Venture Partners
Venture CapitalActiveWindamere Venture Partners, an early-stage investment firm, finances pharmaceutical, biotechnology, and other healthcare companies.
La Jolla, United StatesFounded 2017
10
Investments
6
Exits
—
AUM
60.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Windamere Venture Partners.
Investment Thesis & Strategy
Windamere Venture Partners invests in early-stage pharmaceutical, biotechnology, and healthcare companies. They typically focus on companies with high growth potential and innovative technologies.
Investment Activity
Deals per year over the last 11 years
1
20030
20040
20051
20061
20072
20080
20093
20101
20111
20121
2013Portfolio Companies
Selected investments from their portfolio of 10 companies
C
Cytokinetics
Biotech · Series A, 0
A
Aeglea BioTherapeutics
Biotech · Series A, 2013
C
Cidara Therapeutics
Biotech · Series A, 2012
A
Aridis Pharmaceuticals
Biotech · Series A, 2011
A
Aprea Therapeutics
Biotech · Series A, 2010
R
Rapt Therapeutics
Biotech · Series A, 2010
K
Kala Pharmaceuticals
Biotech · Series A, 2010
F
Fate Therapeutics
Biotech · Series A, 2008
C
Celladon
Biotech · Series A, 2008
C
Concert Pharmaceuticals
Biotech · Series A, 2007
P
Portola Pharmaceuticals
Biotech · Series A, 2006
I
Intra-Cellular Therapies
Biotech · Series A, 2003
Frequently Asked Questions
Windamere Venture Partners focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Avalon Ventures
La Jolla, United States · 166 deals
Enterprise Partners
La Jolla, United States · 116 deals
Rady Venture Fund
La Jolla, United States · 5 deals
Ventana Capital Partners
La Jolla, United States · 2 deals
GC1 Ventures
La Jolla, United States · 1 deals
Succession Capital
La Jolla, United States · 0 deals